Assessment of T Regulatory Cells and Expanded Profiling of Autoantibodies May Offer Novel Biomarkers for the Clinical Management of Systemic Sclerosis and Undifferentiated Connective Tissue Disease

Figure 2

Levels of T reg cells (CD4+/CD25+/FoxP3+) in controls and patients with UCTD or cSSc are significantly different.